Live Price
Live Volume
Chart Volume 0
Volume 0
5 secInhibikase Therapeutics Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $2.34 |
|---|---|
| Close | $2.34 |
| Low | $2.34 |
| Low Change | 0.00 (0.00%) |
| High | $2.34 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 62.212K |
| Dollar Volume | $145.58K |
Regular Trading Hours Yesterday
-0.04(-1.69%)
| Open | $2.37 |
|---|---|
| Close | $2.33 |
| Low | $2.32 |
| Low Change | -0.05 (-2.00%) |
| High | $2.39 |
| High Change | +0.02 (+0.84%) |
| Range | $0.07 |
| Volume | 197.08K |
| Dollar Volume | $459.20K |
Premarket Yesterday
*No Trades in Segment
Inhibikase Therapeutics News
There is no current news for this stock at the moment.
Inhibikase Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Inhibikase Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.40 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.41 |
| 20 Day Moving Average (SMA20) | $2.42 |
| 50 Day Moving Average (SMA50) | $2.30 |
| 100 Day Moving Average (SMA100) | $2.05 |
| 200 Day Moving Average (SMA200) | $1.89 |
Inhibikase Therapeutics Statistics
| Average Volume (30 Days) | 455.35K |
|---|---|
| P/E Ratio (Current) | -5.42 |
| EPS (Current) | -$0.43 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$42.61M |
| Cash Ratio | 3.04 |
| Current Ratio | 15.82 |
| Quick Ratio | 15.82 |
| Debt to Equity | 0.00 |
| Enterprise Value | $293.91M |
| EV to EBITDA | -4.49 |
| EV to Sales | — |
| Price to Book | 2.12 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.37% |
| Return on Equity | -0.40% |
Inhibikase Therapeutics Stock Splits
There has been 1 stock split for Inhibikase Therapeutics (IKT). The reverse stock split occured on June 30, 2023 and reduced the outstanding shares at a ratio of 6:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 30, 2023 | Reverse | 6:1 |
Inhibikase Therapeutics Dividends
There have been no dividends for Inhibikase Therapeutics (IKT).